Gunderson Stephanie, Jungheim Emily S, Kallen Caleb B, Omurtag Kenan
1Department of Obstetrics and Gynecology at Washington University Division of Reproductive Endocrinology St Louis, St. Louis, MO USA.
Department of Obstetrics and Gynecology at Northwestern University Division of Reproductive Endocrinology Chicago, Chicago, IL USA.
Fertil Res Pract. 2020 Feb 11;6:1. doi: 10.1186/s40738-020-00070-7. eCollection 2020.
Since 1992 ART clinics have been required to report outcome data. Our objective was to assess practitioners' opinions of the impact of public reporting of assisted reproductive technology (ART) outcomes on treatment strategies, medical decision-making, and fellow training.
Survey study performed in an academic medical center. Members of the Society of Reproductive Endocrinology and Infertility and the Society of Reproductive Surgery were recruited to participate in an online survey in April 2012. Categorical survey responses were expressed as percentages. Written responses were categorized according to common themes regarding effects of reporting on participants' medical management of patients. The study was primarily qualitative and was not powered to make statistical conclusions.
Of 1019 surveys sent, 323 participants (31.7%) responded from around the United States, and 275 provided complete data. Nearly all (273 of 282; 96.8%) participants responded that public reporting sometimes or always affected other providers' practices, and 264 of 281 (93.9%) responded that other practitioners were motivated to deny care to poor-prognosis patients to improve reported success rates. However, only 121 of 282 (42.9%) indicated that public reporting influenced their own medical management. The majority of respondents agreed that public reporting may hinder adoption of single embryo transfer practices (194 of 299; 64.9%) and contribute to the persistent rate of twinning in in vitro fertilization (187 of 279; 67%). A small majority (153 of 279; 54.8%) felt that public reporting did not benefit fellow training, and 58 (61.7%) of the 94 participants who trained fellows believed that having fellows perform embryo transfers reduced pregnancy rates. A small majority (163 of 277; 58.8%) of respondents reported their ART success rates on clinical websites. However, the majority (200 of 275; 72.7%) of respondents compared their success rates with those of other clinics. Finally, most respondents (211 of 277; 76%) believed that most centers that advertised their success rates did so in ways that were misleading to patients.
Public reporting of ART clinical outcomes is intended to drive improvement, promote trust between patients and providers, and inform consumers and payers. However, providers reported that they modified their practices, felt others denied care to poor-prognosis patients, and limited participation of trainees in procedures in response to public reporting of ART outcomes.
自1992年起,辅助生殖技术(ART)诊所就被要求上报治疗结果数据。我们的目的是评估从业者对于公开报告ART治疗结果对治疗策略、医疗决策以及同行培训的影响的看法。
在一家学术医疗中心开展调查研究。2012年4月,招募了生殖内分泌与不孕学会以及生殖外科学会的成员参与一项在线调查。分类调查回复以百分比形式呈现。书面回复根据关于报告对参与者患者医疗管理影响的共同主题进行分类。该研究主要是定性研究,没有足够的样本量得出统计学结论。
在发出的1019份调查问卷中,来自美国各地的323名参与者(31.7%)进行了回复,其中275人提供了完整数据。几乎所有参与者(282人中的273人;96.8%)回复称公开报告有时或总是会影响其他医疗机构的做法,281人中的264人(93.9%)回复称其他从业者会为了提高报告的成功率而拒绝为预后不良的患者提供治疗。然而,282人中只有121人(42.9%)表示公开报告会影响他们自己的医疗管理。大多数受访者同意公开报告可能会阻碍单胚胎移植技术的采用(299人中的194人;64.9%),并导致体外受精中双胎率居高不下(279人中的187人;67%)。一小部分多数人(279人中的153人;54.8%)认为公开报告对同行培训没有益处,在带教住院医生的94名参与者中,有58人(61.7%)认为让住院医生进行胚胎移植会降低妊娠率。一小部分多数受访者(277人中的163人;58.8%)在临床网站上公布了他们的ART成功率。然而,大多数受访者(275人中的200人;72.7%)将自己的成功率与其他诊所进行了比较。最后,大多数受访者(277人中的211人;76%)认为大多数宣传其成功率的中心是以误导患者的方式进行的。
公开报告ART临床结果旨在推动改进、促进患者与医疗机构之间的信任,并为消费者和支付方提供信息。然而,医疗机构报告称,由于公开报告ART结果,他们改变了自己的做法,感觉其他人拒绝为预后不良的患者提供治疗,并限制了实习生参与相关操作。